Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | November Roundup 2023
Liquid Biopsy (LBx) continued to develop through November, featuring new clinical and research collaborations as well as trial launches and study results.
December 11, 2023
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | November Roundup 2023
Liquid Biopsy (LBx) continued to develop through November, featuring new clinical and research collaborations as well as trial launches and study results.
December 11, 2023
Liquid Biopsy
Blog Article
Clinical Diagnostics
2023 Partnership Update - An Adoption Inflection on the Horizon
In this post, we will be looking back at the 2023 partnership landscape to understand what it might mean for 2024 and beyond.
December 6, 2023
Blog Article
Clinical Diagnostics
2023 Partnership Update - An Adoption Inflection on the Horizon
In this post, we will be looking back at the 2023 partnership landscape to understand what it might mean for 2024 and beyond.
December 6, 2023
Digital Pathology
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | November Roundup 2023
Read about the latest updates in the Next-Generation Therapeutics space in the month of November.
December 1, 2023
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | November Roundup 2023
Read about the latest updates in the Next-Generation Therapeutics space in the month of November.
December 1, 2023
Next-Generation Therapeutics
DeciBio Q&A
Exploring the Frontier of Multiomics: DeciBio Q&A with Peter Fromen, CEO of biomodal
A Q&A with Peter Fromen, CEO of biomodal, emphasizing the potential applications of their technology, particularly in oncology, liquid biopsy, aging, and neurodegenerative disorders.
November 28, 2023
DeciBio Q&A
Exploring the Frontier of Multiomics: DeciBio Q&A with Peter Fromen, CEO of biomodal
A Q&A with Peter Fromen, CEO of biomodal, emphasizing the potential applications of their technology, particularly in oncology, liquid biopsy, aging, and neurodegenerative disorders.
November 28, 2023
Liquid Biopsy
Genomics Market
multiomics
Blog Article
Clinical Diagnostics
Illuminating the Future of Medicine: Insights from SITC 2023 and AMP 2023
AMP and SITC 2023 both showcased the latest advancements and highlighted the shifting paradigms in patient care and laboratory practices.
November 27, 2023
Blog Article
Clinical Diagnostics
Illuminating the Future of Medicine: Insights from SITC 2023 and AMP 2023
AMP and SITC 2023 both showcased the latest advancements and highlighted the shifting paradigms in patient care and laboratory practices.
November 27, 2023
AI / Machine Learning
Immuno-Oncology
Spatial Biology
Webinar
Pharma & Biotech
Revolutionizing Medicine- Navigating the Future of Cell Therapy Manufacturing (DeciBio Webinar)
DeciBio Consulting shares their perspective on how the tools supporting cell therapy manufacturing have evolved and where there is room for continued growth.
November 21, 2023
Webinar
Pharma & Biotech
Revolutionizing Medicine- Navigating the Future of Cell Therapy Manufacturing (DeciBio Webinar)
DeciBio Consulting shares their perspective on how the tools supporting cell therapy manufacturing have evolved and where there is room for continued growth.
November 21, 2023
Cell & Gene Tx
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved